INM
NASDAQ
$1.54
InMed Pharmaceuticals Inc (INM)
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
Sector:
Healthcare
Target: $20 (+1198.70%)
Market Cap
$6.44M
Free Cash Flow Yield
-90.29%
Beta (5Y)
1.13
Price Chart
Valuation
Market Cap$6.44M
P/S1.72
P/B1.20
Profitability
Total Revenue (TTM)$477M
Gross Profit (TTM)$1.23M
EBITDA-$6.64M
Profit Margin-0.4%
Operating Margin-0.4%
Financial Health
Debt-to-Equity6.1%
Free Cash Flow Yield-90.29%
Growth & Risk
FCF 5Y CAGR+1.61%
Beta (5Y)1.13
Sharpe Ratio0.10